BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23446751)

  • 21. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.
    Charbel A; Tavernar L; Albrecht T; Brinkmann F; Verheij J; Roos E; Vogel MN; Köhler B; Springfeld C; Brobeil A; Schirmacher P; Singer S; Mehrabi A; Roessler S; Goeppert B
    Br J Cancer; 2022 Nov; 127(9):1603-1614. PubMed ID: 36068277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
    Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of pediatric biliary intraepithelial neoplasia diagnosed from a choledochal cyst specimen.
    Gang S; Kwon H; Song IH; Namgoong JM
    World J Surg Oncol; 2024 Apr; 22(1):105. PubMed ID: 38643155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges.
    Liu Y; Yeh MM
    Hum Pathol; 2023 Feb; 132():158-168. PubMed ID: 35714833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
    Nakanuma Y; Sasaki M; Sato Y; Ren X; Ikeda H; Harada K
    World J Hepatol; 2009 Oct; 1(1):35-42. PubMed ID: 21160963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic cholangiocarcinoma with extensive intraductal extension of high-grade biliary intraepithelial neoplasia: a case report.
    Kubota H; Hashimoto Y; Toyota K; Yano R; Kobayashi H; Yokoyama Y; Sakashita Y; Taniyama K; Miyamoto K; Murakami Y
    Surg Case Rep; 2023 Sep; 9(1):164. PubMed ID: 37721561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
    Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancerization of ducts in hilar cholangiocarcinoma.
    Lee JW; Zhang Y; Yoshizawa T; Argani P; Wood LD; Oshima K
    Virchows Arch; 2022 Aug; 481(2):1-10. PubMed ID: 35527321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological evidence of intrahepatic cholangiocarcinoma occurring in ductal plate malformation: A clinicopathologic study of 5 cases.
    Wang Q; Xu Y; Wang SM; Hu AY; Pan YC; Zhang SH
    Ann Diagn Pathol; 2021 Dec; 55():151828. PubMed ID: 34571341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
    Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
    J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia.
    Sato Y; Harada K; Sasaki M; Nakanuma Y
    Int J Hepatol; 2014; 2014():678260. PubMed ID: 24860672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.
    Miyazaki T; Shinkawa H; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tsuchi J; Ishihara A; Eguchi S; Shirai D; Yamamoto T; Wakasa K; Kawada N; Kubo S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3647-3654. PubMed ID: 33369464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased alpha-1,4-linked N-acetylglucosamine glycosylation in biliary tract cancer progression from biliary intraepithelial neoplasia to invasive adenocarcinoma.
    Okumura M; Yamanoi K; Uehara T; Nakayama J
    Cancer Sci; 2020 Dec; 111(12):4629-4635. PubMed ID: 33020993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.